World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00538135
Date of registration: 29/09/2007
Primary sponsor: University of Aberdeen
Public title: BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder BOSCOT
Scientific title: BOSCOT: A Randomised Control Trial of Cognitive Behavioural Therapy Plus Treatment as Usual Versus Treatment as Usual in the Treatment of Borderline Personality Disorder
Date of first enrolment: February 2002
Target sample size: 106
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00538135
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United Kingdom
Contacts
Name:   Kate Davidson, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Glasgow
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Aged between 18 and 65.

2. Met criteria for at least 5 items of the borderline personality disorder using the
Structured Clinical Interview for DSM IV Axis II Personality Disorders (SCID
-II)(First, Gibbon, Spitzer, Williams & Benjamin, 1997)

3. Had received either in-patient psychiatric services or an assessment at Accident and
Emergency services or an episode of deliberate self-harm (either suicidal act or
self-mutilation) in the previous 12 months.

4. Able to give informed consent.

Exclusion Criteria:

1. Currently receiving in-patient treatment for a mental state disorder,

2. Currently receiving a systematic psychological therapy or specialist service,
particularly psychodynamic psychotherapy,

3. Insufficient knowledge of English to enable them to be assessed adequately and to
understand the treatment approach,

4. Temporarily resident in the area,

5. The existence of an organic illness, mental impairment, alcohol or drug
dependence, schizophrenia or bipolar affective disorder, as assessed by SCID I,/P (W/
Psychotic Screen)(version 2) (First, Spitzer, Gibbon, Williams, 1996).



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Borderline Personality Disorder
Intervention(s)
Behavioral: Cognitive Behavioural Therapy
Other: Treatment as usual
Primary Outcome(s)
The primary outcome will be the composite outcome of the number of in-patient psychiatric hospitalisations, the number of A& E contacts, and the number of suicidal acts. [Time Frame: At both 12 and 24 months post randomisation.]
Secondary Outcome(s)
Secondary outcome measures include the Brief Symptom Inventory, Beck Depression Inventory-II, State-Trait Anxiety Inventory, Social Functioning Questionnaire, Inventory of Interpersonal Problems, Schema Questionnaire (Young), Euro-Qol (EQ-5D) [Time Frame: 6, 12, 18 and 24 months post randomisation]
Secondary ID(s)
064027/Z/01/Z
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Glasgow
University of London
University of York
Wellcome Trust
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history